Jeppe Romme Christensen

Summary

Affiliation: Copenhagen University Hospital
Country: Denmark

Publications

  1. doi CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
    Jeppe Romme Christensen
    University of Copenhagen and Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark
    Mult Scler 19:877-84. 2013
  2. pmc Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression
    Jeppe Romme Christensen
    Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    PLoS ONE 8:e57820. 2013
  3. pmc Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
    Jeppe Romme Christensen
    Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark
    J Neuroinflammation 9:215. 2012
  4. doi Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
    Lars Börnsen
    Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    PLoS ONE 10:e0118830. 2015
  5. doi Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial
    Jeppe Romme Christensen
    From the Danish Multiple Sclerosis Center J R C, R R, L B, P S S, F S, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen Danish Research Center for Magnetic Resonance M L, E G, T B D, H R S, Copenhagen University Hospital Hvidovre, Denmark
    Neurology 82:1499-507. 2014

Collaborators

Detail Information

Publications5

  1. doi CSF inflammation and axonal damage are increased and correlate in progressive multiple sclerosis
    Jeppe Romme Christensen
    University of Copenhagen and Department of Neurology, Copenhagen University Hospital Rigshospitalet, Denmark
    Mult Scler 19:877-84. 2013
    ..The mechanism underlying disease progression in progressive multiple sclerosis (MS) is uncertain. Pathological studies found widespread inflammation in progressive MS brains correlating with disease progression and axonal damage...
  2. pmc Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression
    Jeppe Romme Christensen
    Department of Neurology, University of Copenhagen, Rigshospitalet, Copenhagen, Denmark
    PLoS ONE 8:e57820. 2013
    ..These observations may have implications for the treatment of progressive MS...
  3. pmc Cellular sources of dysregulated cytokines in relapsing-remitting multiple sclerosis
    Jeppe Romme Christensen
    Department of Neurology, Danish Multiple Sclerosis Center, Copenhagen University Hospital Rigshospitalet, Blegdamsvej 9, Copenhagen, 2100, Denmark
    J Neuroinflammation 9:215. 2012
    ..Knowledge about the relation between blood and cerebrospinal fluid (CSF) cell expression of cytokines and the cellular source of CSF cytokines is even more scarce...
  4. doi Endogenous Interferon-β-Inducible Gene Expression and Interferon-β-Treatment Are Associated with Reduced T Cell Responses to Myelin Basic Protein in Multiple Sclerosis
    Lars Börnsen
    Danish Multiple Sclerosis Center, Department of Neurology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
    PLoS ONE 10:e0118830. 2015
    ..Reduced myelin basic protein-induced CD4+ T-cell autoreactivity in interferon-β-treated multiple sclerosis patients may be mediated by monocyte-derived interleukin-10. ..
  5. doi Natalizumab in progressive MS: results of an open-label, phase 2A, proof-of-concept trial
    Jeppe Romme Christensen
    From the Danish Multiple Sclerosis Center J R C, R R, L B, P S S, F S, Department of Neurology, Copenhagen University Hospital, Rigshospitalet, Copenhagen Danish Research Center for Magnetic Resonance M L, E G, T B D, H R S, Copenhagen University Hospital Hvidovre, Denmark
    Neurology 82:1499-507. 2014
    ..Natalizumab inhibits the migration of systemic immune cells to the CNS and may be beneficial in progressive multiple sclerosis (MS). The objective of the study was to examine the effects of natalizumab in progressive MS...